Shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) were up 12.4% as of 11:32 a.m. EDT on Wednesday. The stock's jump stemmed from the biotech's announcement of its second-quarter results after the market closed on Tuesday.Inovio is a clinical-stage biotech with no products on the market. The reality is that its financial results in a given quarter don't mean a lot.